Suhexiang Pill for Acute Ischemic Stroke: A Registry Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Suhexiang Pill for Acute Ischemic Stroke: A Registry Study — Stella

Home/Ischemic Stroke/

View on ClinicalTrials.gov

Recruiting

Back to Ischemic Stroke trials

Trial locations(2 sites)

China

Dongzhimen Hospital, Beijing, Beijing Municipality

Dongzhimen Hospital, Beijing, Beijing Municipality

Key details

Sponsor

Dongzhimen Hospital, Beijing

Enrollment target

~1,000 participants

Started

June 2023

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.